Table 1.

Details of trials included in this meta-analysis

TC, total cholesterol; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol; FBG, fasting blood glucose; SBP, systolic blood pressure; DBP, diastolic blood pressure; RCT, randomized controlled trial; DB, double-blind; SB, single-blind; Y(++), significant improvement in the biomarker compared to control; Y(+), significant improvement in the biomarker compared to before the treatment; N, no significant improvement in the biomarker; DM, diabetes mellitus; PAOD, Peripheral arterial occlusive disease; CHD, coronary heart disease